Zenrelia vs. Apoquel vs. Cytopoint: Differences, Vaccine Warning and Alternatives
Zenrelia arrived in 2024 as the first real challenger to Apoquel: another daily tablet for itchy dogs, from Elanco instead of Zoetis. Since then it has picked up a head-to-head study, a label change and a lot of questions from owners. If your vet has suggested Zenrelia, or you're wondering whether it's the right swap for Apoquel or Cytopoint, here's how they compare, what the vaccine warning actually means, and what the alternatives are.
Key Takeaways
- Zenrelia (ilunocitinib) is a once-daily JAK inhibitor tablet, the same drug class as Apoquel, approved for dogs 12 months and older.
- In an Elanco-funded trial of 338 dogs, it matched Apoquel at day 28 and scored better over the following months.
- Its label carries a boxed warning about vaccines: stop it before vaccinations and wait at least 28 days after.
- Cytopoint is an injection that blocks one itch signal, with no vaccine-timing restriction and no age limit.
- All three control itch. None of them changes the underlying allergy.
How Each One Works
Zenrelia and Apoquel are Janus kinase (JAK) inhibitors. Itch and inflammation messengers released during an allergic reaction pass their signal into cells through JAK enzymes. Blocking those enzymes quiets several signals at once, so these drugs reduce both itch and inflammation. A newer drug in the same class, Numelvi, launched in 2026; we compare it in Numelvi vs. Apoquel vs. Cytopoint.
Cytopoint is a monoclonal antibody. Rather than blocking the cell's machinery, it binds one messenger, interleukin-31 (IL-31), before it reaches the nerves in the skin. It's given as an injection every four to eight weeks. Befrena, also from Elanco, works the same way.
At a Glance
| Zenrelia | Apoquel | Cytopoint | |
|---|---|---|---|
| Active ingredient | Ilunocitinib | Oclacitinib | Lokivetmab |
| Maker | Elanco | Zoetis | Zoetis |
| Type | JAK inhibitor | JAK inhibitor | Anti-IL-31 antibody |
| How it's given | Tablet | Tablet or chewable | Injection at the clinic |
| How often | Once daily from day one | Twice daily up to 14 days, then once daily | Every 4–8 weeks |
| Minimum age | 12 months | 12 months | No age limit |
| Vaccine timing warning | Yes (boxed warning) | No | No |
| On the US market | Since 2024 | Since 2013 | Since 2016 |
| Treats the underlying allergy? | No | No | No |
Zenrelia vs. Apoquel: What the Study Found
Zenrelia is one of the few itch drugs with a published head-to-head trial. In the study, published in Veterinary Dermatology in 2025, 338 client-owned dogs with atopic dermatitis were randomly assigned to Zenrelia once daily or Apoquel as labeled (twice daily for up to 14 days, then once daily). At the main checkpoint, day 28, Zenrelia was as effective as Apoquel on both owner-rated itch and vet-scored skin lesions, using the CADESI-4 scale. From day 28 through day 112, itch and skin scores were significantly lower in the Zenrelia group, and more of those dogs reached remission of itch. Side-effect rates were similar.
Two caveats are worth knowing. The study was funded by Elanco, the maker of Zenrelia. And a single trial is a starting point, not the final word; your own dog's response is what counts. Still, it's more direct evidence than exists for most of these comparisons.
The other practical difference is dosing. Zenrelia is once a day from the first dose, while Apoquel starts twice a day. On cost, Elanco says that at label dose Zenrelia's list price is lower than Apoquel's, though what you pay depends on your dog's weight and where you buy it. If price is the main concern, see Is There a Generic Apoquel?.
The Vaccine Warning, Explained
Zenrelia's label has a boxed warning, the FDA's most prominent kind, about vaccines. When it was first approved, the warning covered two concerns: a risk of fatal disease from modified-live vaccines, and the risk that vaccines might not work as well. Both came from a laboratory study in young dogs given three times the label dose, some of which had another illness at the time.
In September 2025, after reviewing additional data, the FDA approved removing the fatal vaccine-induced disease language. The boxed warning about an inadequate immune response to vaccines remains. In practice, that means:
- Your dog should be up to date on vaccines before starting Zenrelia.
- Zenrelia should be stopped for 28 days to 3 months before a vaccination.
- It should be withheld for at least 28 days after the vaccination.
For many adult dogs on a predictable vaccine schedule, that's manageable with some planning. For puppies still finishing their series, dogs that need frequent boosters, or owners who'd rather not manage the gaps, Apoquel, Numelvi or Cytopoint may be simpler. Your vet can tell you how it fits your dog's schedule.
Zenrelia vs. Cytopoint
This comes down to format and fit. Zenrelia is a pill at home every day, acting on several itch and inflammation signals. Cytopoint is a shot every month or two, acting on one itch signal, with no age limit and no vaccine-timing restriction. Dogs whose itch comes with a lot of skin inflammation may do better on a JAK inhibitor; dogs who are hard to pill, or owners who prefer fewer daily tasks, may prefer an injection. We compare Cytopoint with its newer rival in Befrena vs. Cytopoint.
Bring a Comparison Chart to Your Vet
Get a printable one-page chart of every itch and allergy option for dogs, with questions to ask at your next visit.
Alternatives to Zenrelia
If Zenrelia isn't the right fit, whether because of the vaccine timing, side effects or simply not enough relief, there are several directions to go:
- Another JAK inhibitor. Apoquel and Numelvi work the same way without the vaccine-timing warning. Numelvi is also labeled for dogs from six months.
- An anti-itch injection. Cytopoint or Befrena, every four to eight weeks, given at the clinic.
- Cyclosporine. A daily medication that calms the immune response more broadly, with generic versions available. It takes several weeks to reach full effect.
- Allergen immunotherapy. The only option aimed at the allergy itself rather than the itch.
Our guide to alternatives to Apoquel and Cytopoint covers all of them in more depth.
What None of Them Do
Zenrelia, Apoquel and Cytopoint all control itch for as long as your dog takes them. They don't change what your dog's immune system is reacting to, so the itch generally returns when treatment stops. Allergen immunotherapy uses small, gradually increasing amounts of the specific allergens your dog tested positive for, so the immune system learns to tolerate them. The ICADA treatment guidelines recognize it as the treatment aimed at the allergic response itself. It takes months to work, so it's usually started alongside an itch controller, which can be reduced as the immunotherapy takes hold.
Treat the Allergy, Not Just the Itch
Allibre is a once-daily immunotherapy cream for dogs and cats, custom-formulated from your pet's allergy-testing results and rubbed on the inside of the ear. No needles, no pills, and it can be started alongside Zenrelia, Apoquel or Cytopoint. It's prescribed by your vet, so the first step is asking them about it.
How to get Allibre for your petCommon Questions
Is Zenrelia better than Apoquel? In Elanco's head-to-head trial of 338 dogs, Zenrelia was as effective as Apoquel at day 28, and itch and skin scores were lower with Zenrelia over the following months. The study was funded by Elanco, and individual dogs vary. Apoquel has no vaccine-timing warning and a longer track record. Your vet can help you weigh both.
What is the Zenrelia vaccine warning? Zenrelia's label carries a boxed warning that dogs taking it may not respond adequately to vaccines. It advises stopping Zenrelia for 28 days to 3 months before vaccination and withholding it for at least 28 days afterward. In September 2025 the FDA removed the original language about fatal vaccine-induced disease, but the timing guidance remains.
What is a good alternative to Zenrelia? If you want another daily tablet, Apoquel and Numelvi work the same way without Zenrelia's vaccine-timing warning. If you'd rather avoid daily pills, Cytopoint or Befrena injections block the itch signal every four to eight weeks. Cyclosporine is another option. To treat the allergy itself, ask about allergen immunotherapy.
Is Zenrelia cheaper than Apoquel? Elanco says that at label dose, Zenrelia's list price is lower than Apoquel's. What you actually pay depends on your dog's weight and your clinic or pharmacy, so ask for a monthly quote for both.
Can Zenrelia and Cytopoint be given together? They work in different ways, and vets sometimes combine a daily tablet with an anti-itch injection for hard-to-control dogs. It isn't a labeled combination, so it's a decision for your vet based on your dog's case.
Can cats take Zenrelia? No. Zenrelia is labeled for dogs 12 months and older. For cats, vets commonly use steroids, cyclosporine or allergen immunotherapy. Allibre is formulated for both dogs and cats.
- Forster et al. Comparative efficacy and safety of ilunocitinib and oclacitinib in dogs with atopic dermatitis. Vet Dermatol, 2025
- FDA: approval of Zenrelia (ilunocitinib), 2024
- AAHA: FDA removes some vaccine-related warnings from the Zenrelia label, 2025
- dvm360: FDA approves updated US label for Zenrelia
- Cytopoint product information (Zoetis)
- ICADA 2015 treatment guidelines for canine atopic dermatitis
Allibre is ordered by veterinarians only. Ask yours if it’s right for your pet.
Ask Your Vet